Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Xiangzhong Wu"'
Autor:
Bin Liu, Mengyi Zhan, Yingzhan Zhang, Hui Li, Xiangzhong Wu, Fengfeng Zhuang, Wenhong Luo, Yingbi Zhou
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract This study aimed to determine whether E prostanoid receptor-3 (EP3) is involved in prostacyclin (PGI2)-evoked vasoconstrictor activity of resistance arteries and if so, how it changes under hypertensive conditions. Mesenteric resistance arte
Externí odkaz:
https://doaj.org/article/3959dd6fbf1a46b1a320225dbfd20719
Autor:
Chuangjia Hu, Bin Liu, Yineng Xu, Xiangzhong Wu, Tingting Guo, Yingzhan Zhang, Jing Leng, Jiahui Ge, Gang Yu, Jinwei Guo, Yingbi Zhou
Publikováno v:
Frontiers in Physiology, Vol 10 (2019)
Endothelial dysfunction, which leads to ischemic events under atherosclerotic conditions, can be attenuated by antagonizing the thromboxane-prostanoid receptor (TP) that mediates the vasoconstrictor effect of prostanoids including prostacyclin (PGI2)
Externí odkaz:
https://doaj.org/article/544243e40ccc44048c6172fc383601fd
Autor:
Gang Yu, Jing Leng, Jinwei Guo, Ruhui Zeng, Bin Liu, Yingbi Zhou, Yingzhan Zhang, Yineng Xu, Jiahui Ge, Tingting Guo, Xiangzhong Wu, Yehu Yin
Publikováno v:
The FASEB Journal. 34:2568-2578
Although recognized to have an in vivo vasodepressor effect blunted by the vasoconstrictor effect of E-prostanoid receptor-3 (EP3), prostaglandin E2 (PGE2 ) evokes contractions of many vascular beds that are sensitive to antagonizing the thromboxane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6210491cb415f28cc1bc889f2f5555db
https://doi.org/10.1096/fj.201901611r
https://doi.org/10.1096/fj.201901611r
Publikováno v:
Heartlung : the journal of critical care. 50(6)
Background Studies evaluating the association of blood level of N-terminal pro-brain natriuretic peptide (NT-proBNP) with adverse prognosis have yielded conflicting results in patients with acute myocardial infarction (AMI). This meta-analysis sought
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74195bf86850c7d13420e073b82c63b
https://pubmed.ncbi.nlm.nih.gov/34340134
https://pubmed.ncbi.nlm.nih.gov/34340134
Autor:
Wenhong Luo, Hongfei Yan, Tingting Guo, Dongping Tian, Xiangzhong Wu, Jiarong Li, Yingzhan Zhang, Hui Li, Yingbi Zhou, Bin Liu
Publikováno v:
The FASEB Journal. 33:2451-2459
The vasoconstrictor and/or pressor effects of prostaglandin (PG)F2α participate in the development of vascular pathologies and limit the clinical use of the agent. This study aimed to determine the receptor types responsible for the vasoconstrictor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f749d37af13d97bea7ae31aab71beb53
https://doi.org/10.1096/fj.201801064rr
https://doi.org/10.1096/fj.201801064rr
Publikováno v:
European Journal of Pharmacology. 836:11-17
Prostaglandin (PG) D2, a prostanoid known to have hypotensive effect, can evoke increased in vitro prepartum myometrial contraction resulting from up-regulation of the F prostanoid (FP) receptor. The present study further determined postpartum rat ut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99619c7d8ee89a0d578778b5b29d0dc0
https://doi.org/10.1016/j.ejphar.2018.08.012
https://doi.org/10.1016/j.ejphar.2018.08.012
Autor:
Bin, Liu, Xiangzhong, Wu, Ruhui, Zeng, Yehu, Yin, Tingting, Guo, Yineng, Xu, Yingzhan, Zhang, Jing, Leng, Jiahui, Ge, Gang, Yu, Jinwei, Guo, Yingbi, Zhou
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 34(2)
Although recognized to have an in vivo vasodepressor effect blunted by the vasoconstrictor effect of E-prostanoid receptor-3 (EP3), prostaglandin E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7171a727c70dc7a3c539ab92cfd8c7a0
https://pubmed.ncbi.nlm.nih.gov/31908041
https://pubmed.ncbi.nlm.nih.gov/31908041
Autor:
Gang Yu, Jinwei Guo, Yingbi Zhou, Yineng Xu, Tingting Guo, Bin Liu, Chuangjia Hu, Jing Leng, Jiahui Ge, Xiangzhong Wu, Yingzhan Zhang
Publikováno v:
Frontiers in Physiology
Frontiers in Physiology, Vol 10 (2019)
Frontiers in Physiology, Vol 10 (2019)
Endothelial dysfunction, which leads to ischemic events under atherosclerotic conditions, can be attenuated by antagonizing the thromboxane-prostanoid receptor (TP) that mediates the vasoconstrictor effect of prostanoids including prostacyclin (PGI2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::096b9d6822e124f5de3eb1171b2a16c0
https://pubmed.ncbi.nlm.nih.gov/31611817
https://pubmed.ncbi.nlm.nih.gov/31611817
Autor:
Xiangzhong Wu, Jinwei Guo, Tingting Guo, Juyu Cai, Ningxia Zhu, Yingzhan Zhang, Yingbi Zhou, Bin Liu, Jing Leng
Publikováno v:
European Journal of Pharmacology. 882:173254
Diabetic nephropathy (DN), one of the main causes of end-stage renal disease, still remains as a challenge of clinical management. This study aimed to determine whether deficiency of the thromboxane (TX) prostanoid receptor (TP), which mediates the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c8731aab49222216d0c1696fc87e36
https://doi.org/10.1016/j.ejphar.2020.173254
https://doi.org/10.1016/j.ejphar.2020.173254
Autor:
Bin, Liu, Jiarong, Li, Hongfei, Yan, Dongping, Tian, Hui, Li, Yingzhan, Zhang, Tingting, Guo, Xiangzhong, Wu, Wenhong, Luo, Yingbi, Zhou
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 33(2)
The vasoconstrictor and/or pressor effects of prostaglandin (PG)F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dffdbe2f782b2f8fb7d233b4ab2fce65
https://pubmed.ncbi.nlm.nih.gov/30277822
https://pubmed.ncbi.nlm.nih.gov/30277822